MicroPort CardioFlow IPO Initiation: To Save a Life
MicroPort is pre-marketing for an HK IPO to raise $300 million. With a large addressable market opportunity and VitaFlowās potentially best-in...
955 Views
ECM Weekly (17 January 2021) - RLX Tech, Kuaishou, PTT Retail, MicroPort CardioFlow, New Horizon
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
819 Views
MicroPort Cardioflow (å¾®ååæé) Pre-IPO: Strong Sales Ramp-Up Despite Being Late in Market
The company's first-generation TAVR, VitaFlow, has decent clinical data in terms of efficacy and safety. It was launched two years behind VenusA...
628 Views
ECM Weekly (10 January 2021) - RLX Technology, Roiserv, Yidu Tech, and Placements
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
602 Views
Microport Cardioflow: Winning in TAVR
We provide our initial thoughts on the proposed listing of medical device (TAVR) company MicroPort Cardioflow on the HKEX.
550 Views